The Bone Marrow and Stem Cell Transplantation Program is the only comprehensive, state-of the-art dedicated blood and marrow transplantation program in Jordan and is one of the largest programs in the Eastern Mediterranean region performing most sophisticated blood and marrow transplantation procedures. The King Hussein Cancer Center BMT program has high success and cure rates comparable with those of international programs and centers. The Bone Marrow and Stem Cell Program has been a well-established program since 2003 and has evolved into a comprehensive center of excellence providing state-of-the-art care performing approximately 300 transplants annually and has completed more than 3500 transplants procedures.
Since its establishment, The Bone Marrow and Stem Cell Transplantation Program at the King Hussein Cancer Center (KHCC) has had a transformative impact at both the national regional and international levels. Nationally, the program has enabled Jordanian patients with malignant and non-malignant conditions, bone marrow failure syndromes, inherited disorders, and other life-threatening conditions to access world-class bone marrow transplantation and advanced cellular therapies locally including CAR-T cell therapy, significantly reducing the need for treatment abroad ,reduced the need for overseas referrals, lowered healthcare costs, improved access to timely treatment, and enhanced survival outcomes for patients and their families. The program has performed more than 3500 autologous and allogeneic stem cell transplants, while building a highly specialized multidisciplinary workforce and developing national expertise in transplantation, cell processing, apheresis, and supportive care. Regionally, KHCC has emerged as a leading referral center for patients from neighboring countries and a hub for education, training, and capacity building in hematopoietic cell transplantation and cellular therapy. Initial treatments were conducted through international partnerships and technology transfer programs, and patients referrals outside the country, followed by the development of local expertise and independent manufacturing capabilities at The King Hussein Cancer Centre.